Growth Metrics

Astrana Health (ASTH) Gains from Sales and Divestitures (2024 - 2025)

Astrana Health (ASTH) has disclosed Gains from Sales and Divestitures for 2 consecutive years, with $363061.0 as the latest value for Q4 2025.

  • Quarterly Gains from Sales and Divestitures rose 364.24% to $363061.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $363061.0 through Dec 2025, up 364.24% year-over-year, with the annual reading at $363061.0 for FY2025, 364.24% up from the prior year.
  • Gains from Sales and Divestitures hit $363061.0 in Q4 2025 for Astrana Health, up from $78206.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $363061.0 in Q4 2025 to a low of $78206.0 in Q4 2024.